Global Pharmaceutical Industry Calls on Governments to Work with Them to Beat the Rising Threat of Drug Resistance

21 January 2016

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology […]

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

21 January 2016

Antimicrobials, and specifically antibiotics, play a crucial role in modern […]

Spain and Europe Join Forces To Bring Access To Generic Medicines To The Market

19 January 2016

Barcelona – At their joint Executive meeting in Barcelona today, the […]

Ethics: EGA Adopts Disclosure Requirements For The Generic, Biosimilar And Value Added Medicines Industry

15 January 2016

Brussels – Today, EGA members unanimously adopted disclosure rules for the […]

Generic and Biosimilar Medicines Essential for Italian Healthcare System

8 January 2016

Brussels – Generic and biosimilar medicines represent an essential opportunity to […]

Para Permitirse los Fármacos Innovadores Hay que Apoyar los Genéricos

22 November 2015

EFG: la EGA Califica de “Mala Noticia” la Eliminación de la Discriminación Positiva

17 November 2015

Les génériques rament pour accéder au marché

7 October 2015

A Comprehensive And Fair Solution To The Price Of Medicines

7 October 2015

After a long dry spell, the pharmaceutical research industry has […]

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]